Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-Associated Steatotic Liver Disease”

226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 226 results

Testing effectiveness (Phase 2)Looking for participantsNCT07481734
What this trial is testing

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Who this might be right for
Metabolic Associated Steatotic Liver DiseaseNonalcoholic SteatohepatitisHepatic Steatosis
Hudson Biotech 120
Not applicableActive Not RecruitingNCT06854185
What this trial is testing

Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseOverweight (BMI > 25)Metabolic Syndrome
Baylor College of Medicine 50
Not applicableNot Yet RecruitingNCT07750210
What this trial is testing

Study of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults With Type 1 Diabetes

Who this might be right for
MASLDType 1 Diabetes
Sohag University 250
Not applicableNot Yet RecruitingNCT06795646
What this trial is testing

Clinical Classification of MAFLD Based Liver Biopsy

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseMetabolic Dysfunction-associated Steatohepatitis (MASH)
Beijing Friendship Hospital 2,000
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Not applicableLooking for participantsNCT06868992
What this trial is testing

Study of the Link Between MASH ( Metabolic Dysfunction-Associated Steatohepatitis) and MAMs (Mitochondria-Associated Membranes ) Alteration in Patients Undergoing Bariatric Surgery - MAMBA

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated SteatohepatitisSleeve Gastrectomy+1 more
Hospices Civils de Lyon 20
Not applicableLooking for participantsNCT07683065
What this trial is testing

Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD

Who this might be right for
Plaque PsoriasisMetabolic Dysfunction-Associated Steatotic Liver Disease
Novartis Pharmaceuticals 150
Post-approval studies (Phase 4)Not Yet RecruitingNCT07071636
What this trial is testing

Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseChronic Hepatitis B
Shenzhen Third People's Hospital 830
Not applicableActive Not RecruitingNCT06905795
What this trial is testing

Screening and Intervention of MASLD in Children

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseChildren
Ningbo No. 1 Hospital 270
Not applicableNot Yet RecruitingNCT07430501
What this trial is testing

Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Hospital Universitari Vall d'Hebron Research Institute 7,720
Not applicableLooking for participantsNCT07313007
What this trial is testing

Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Hospices Civils de Lyon 24
Not applicableEnrolling By InvitationNCT07001865
What this trial is testing

Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolically Healthy ObesityHyperuricemia
Ningbo No. 1 Hospital 17,040
Not applicableStudy completedNCT07265011
What this trial is testing

Ultrasound-Based Estimation of Hepatic Steatosis in Pediatric MASLD

Who this might be right for
MASLDPediatric
Jae Won Choi 50
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Not applicableStudy completedNCT07548970
What this trial is testing

Identification and Characterization of At-risk MASLD in Turkish Adults

Who this might be right for
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)Mediterranean DietLifestyle (Sedentary Behavior and Physical Activity)+3 more
Maastricht University Medical Center 459
Not applicableLooking for participantsNCT07652892
What this trial is testing

Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective.

Who this might be right for
Steatosis of Liver
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 140
Not applicableNot Yet RecruitingNCT06843421
What this trial is testing

Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseCardiovascular Diseases
Korea University 6,000
Not applicableLooking for participantsNCT06386094
What this trial is testing

Cardiac Dysfunction in Patients with Fatty Liver Disease

Who this might be right for
NAFLDCardiac DiseaseFatty Liver+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 150
Not applicableNot Yet RecruitingNCT07451366
What this trial is testing

Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Lean MASLD
Assiut University 200
Next Page